Clinical Trials Browser

Phase 1 × Carcinoma, Non-Small-Cell Lung × Antineoplastic Agents × Clear all

NCT05573373 2024-01-31

Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer

Phase 1 Unknown

Carcinoma, Non-Small-Cell Lung